Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
Search Medicine Database
Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
menu
Home
Active Ingredients
Abatacept
Abatacept
Medicine
Status
Monitoring
SPC
PIL
XPIL
Legal Category
Active Ingredient(s)
Company
ORENCIA 125 mg solution for injection in pre-filled pen
Updated
SPC
PIL
Yes
A
Abatacept
Bristol-Myers Squibb Pharma EEIG
ORENCIA 250 mg powder for concentrate for solution for infusion
Updated
SPC
PIL
Yes
A
Abatacept
Bristol-Myers Squibb Pharma EEIG
ORENCIA 50 mg, 87.5 mg and 125 mg solution for injection (pre-filled syringe)
Updated
SPC
PIL
Yes
A
Abatacept
Bristol-Myers Squibb Pharma EEIG
Cookies
Direct Healthcare Professional Communications
Documents associated with this medicine were updated in the last 30 days.
Product subject to medical prescription which may not be renewed (A)